| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:60044678:1572 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:60044678:1572?format=raw |
LEADER: 01572mam a2200373 a 4500
001 4052642
005 20221027024906.0
008 960827t19971997nyua b 001 0 eng c
010 $a 96043029
020 $a0412115417 (alk. paper)
020 $a354061950X (International : alk. paper)
035 $a(OCoLC)ocm35450502
035 $9ALU8488HS
035 $a(NNC)4052642
035 $a4052642
040 $aDNLM/DLC$cDLC$dNLM$dNOH
050 00 $aRC607.A26$bA545 1997
060 10 $aQV 185$bA629 1996
082 00 $a616.97/92061$220
245 00 $aAnti-HIV nucleosides :$bpast, present, and future /$c[edited by] Hiroaki Mitsuya.
260 $aNew York :$bSpringer ;$aAustin :$bR.G. Landes,$c[1997], ©1997.
300 $a178 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aMedical intelligence unit
504 $aIncludes bibliographical references and index.
650 0 $aNucleosides$xDerivatives$xTherapeutic use.
650 0 $aAIDS (Disease)$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh2009114517
650 12 $aNucleosides$xpharmacology.$0https://id.nlm.nih.gov/mesh/D009705Q000494
650 22 $aAnti-Infective Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000890Q000494
650 22 $aHIV$xdrug effects.$0https://id.nlm.nih.gov/mesh/D006678Q000187
700 1 $aMitsuya, Hiroaki,$d1950-$0http://id.loc.gov/authorities/names/n96802660
830 0 $aMedical intelligence unit.$0http://id.loc.gov/authorities/names/n2001021011
852 00 $boff,hsl$hRC607.A26$iA545 1997